APA (7th ed.) Citation

Bodei, L., Kidd, M., Paganelli, G., Grana, C., Drozdov, I., Cremonesi, M., . . . Modlin, I. (2015). Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: The value and limitations of clinical factors. European Journal of Nuclear Medicine & Molecular Imaging, 42(1), 5. https://doi.org/10.1007/s00259-014-2893-5

Chicago Style (17th ed.) Citation

Bodei, Lisa, et al. "Long-term Tolerability of PRRT in 807 Patients with Neuroendocrine Tumours: The Value and Limitations of Clinical Factors." European Journal of Nuclear Medicine & Molecular Imaging 42, no. 1 (2015): 5. https://doi.org/10.1007/s00259-014-2893-5.

MLA (9th ed.) Citation

Bodei, Lisa, et al. "Long-term Tolerability of PRRT in 807 Patients with Neuroendocrine Tumours: The Value and Limitations of Clinical Factors." European Journal of Nuclear Medicine & Molecular Imaging, vol. 42, no. 1, 2015, p. 5, https://doi.org/10.1007/s00259-014-2893-5.